MarketCap
Facebook
X
TelegramPRA Health Sciences, Inc. Total Current Liabilities 2011-2026 | PRAH
Annual Total Current Liabilities PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.27 B | 1.02 B | 899 M | 972 M | 564 M | 530 M | 466 M | 469 M | 306 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 B | 306 M | 721 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 202.18 | -0.43 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 88.24 | -0.35 % | $ 4.13 B | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 3.78 | -11.89 % | $ 5.03 M | USA |
 |
Fulgent Genetics
FLGT
|
85 M | $ 18.35 | -1.77 % | $ 565 M | USA |
 |
Castle Biosciences
CSTL
|
68.7 M | $ 20.66 | -0.19 % | $ 599 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
31.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
303 M | $ 129.82 | -1.37 % | $ 16.3 B | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.58 | -1.56 % | $ 6.99 M | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 24.08 | 4.83 % | $ 1.28 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M |  Israel |
 |
Illumina
ILMN
|
1.58 B | $ 166.89 | 3.68 % | $ 25.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
3.2 B | $ 147.72 | 1.05 % | $ 11.6 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 154.47 | 2.03 % | $ 23.8 B |  Schweiz |
 |
National Research Corporation
NRC
|
36.6 M | $ 18.31 | -2.55 % | $ 410 M | USA |
 |
Natera
NTRA
|
441 M | $ 216.97 | 2.31 % | $ 29.7 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 104.67 | 0.14 % | $ 7.06 B | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 188.47 | 0.51 % | $ 9.34 B | USA |
 |
Pacific Biosciences of California
PACB
|
72.8 M | $ 1.32 | 0.76 % | $ 396 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 467.5 | 0.03 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 11.09 | -0.54 % | $ 1.42 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.32 | -0.23 % | $ 400 M | USA |
 |
Personalis
PSNL
|
39.6 M | $ 9.79 | 2.09 % | $ 874 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 7.24 | 0.84 % | $ 302 M | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
61.4 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.0 | -2.44 % | $ 4.59 M | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 80.79 | 6.07 % | $ 4.83 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 265.03 | -0.42 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 473.72 | 1.03 % | $ 179 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.3 | 2.2 % | $ 2.02 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |